| Compound | Triptorelin Acetate |
|---|---|
| Category | Approved GnRH agonist |
| Class | Other Injectables |
| Evidence tier | Approved medicine |
| WADA status | Prohibited in sport (or falls under a prohibited class) — see the WADA reference table |
| Sold on this site | No — this is a reference database |
Overview
Triptorelin Acetate is catalogued here as a approved gnrh agonist and graded at the "Approved medicine" evidence tier. This compound exists as an approved medicine in at least one major jurisdiction. Approval applies to specific, labeled indications and to the regulated product — not to compounded or research-grade copies.
A long-acting GnRH agonist approved for advanced prostate cancer, precocious puberty, and other hormone-dependent conditions.
Mechanism of Action
Chronic triptorelin exposure downregulates pituitary GnRH receptors, suppressing testosterone to castration levels in prostate cancer therapy.
Research and Evidence
Registrational evidence across approved indications is standard oncology/endocrinology grade.
Safety and Side Effects
Testosterone suppression carries bone, metabolic, and quality-of-life consequences requiring management; misuse to suppress hormones outside care is hazardous.
Frequently Asked Questions
What is the evidence tier of Triptorelin Acetate?
Triptorelin Acetate is graded "Approved medicine" on this site. This compound exists as an approved medicine in at least one major jurisdiction. Approval applies to specific, labeled indications and to the regulated product — not to compounded or research-grade copies.
Is Triptorelin Acetate an approved medicine?
Triptorelin Acetate exists as an approved medicine in at least one major jurisdiction — but approval covers the regulated product and its labeled indications only. Compounded or research-grade versions of the same molecule are not the approved product.
Where can I read the primary studies for Triptorelin Acetate?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
Evidence tier: Approved medicine · Last reviewed: 2026-09-05 · Sources cited below.